PeptideDB

ARS-2102

CAS: 2098509-21-6 F: C28H31ClF2N6O2 W: 557.03

ARS-2102 is a potent covalent KRAS G12C inhibitor for use in cancer research.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity ARS-2102 is a potent covalent KRAS G12C inhibitor for use in cancer research[1].
Name ARS-2102
CAS 2098509-21-6
Formula C28H31ClF2N6O2
Molar Mass 557.03
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Xiaogen Yang, et al. Hindered Biaryl Bond Construction and Subsequent Diastereomeric Crystallization to Produce an Atropisomeric Covalent KRASG12C Inhibitor ARS-2102.Org. Process Res. Dev. 2022.